The authors showed that miR-148-3p levels were decreased in the serum of AD patients, but also in amyloid precursor protein/presenilin-1 (APP/PS1) and SAMP8 (senescence-accelerated mouse prone 8) transgenic mice brain tissue. Here, APP is linked to Alzheimer disease.